W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q4 report for ELEVATEBIO on January 20, 2026, reporting $30,000 in lobbying income.

Lobbying for ELEVATEBIO · Cell and gene therapy.

All filings by W STRATEGIES, LLC · Everything ELEVATEBIO has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Apr 16, 2026.

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbyists on this filing 1

DARREN WILLCOX

Previously held: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 1

Health Issues

Education about innovation in cell and gene therapies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.